Menu
Sign In Pricing Add Podcast
Podcast Image

Wall Street Breakfast

Solid Biosciences gets FDA okay for DMD trial

Wed, 15 Nov 2023

Description

Solid Biosciences (SLDB) gets FDA okay for clinical testing of DMD gene therapy. (00:26) Chevron (CVX) reviewing options for Texas Haynesville shale assets - Reuters. (02:01) U.S. House clears stopgap spending bill to avoid government shutdown, Senate vote next. (02:53) Episode transcripts seekingalpha.com/wsb.Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.Show links: Biggest stock movers today: JD.com, Arcturus Therapeutics and moreChina reset? Big business, Biden set to meet with Xi JinpingWall Street’s 20 most overbought stocksC3.ai soars on expansion of AWS deal focused on generative AI

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

No transcription available yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.